Latest News and Press Releases

APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life...

Codetta Bio debuts its Concerto™ System at AACR 2025—an all-in-one multi-omics platform with early access for 50 pioneering researchers.

Codetta Bio debuts its Concerto™ System at AACR 2025, enabling simultaneous protein, DNA & RNA quantification from one sample. Visit booth 2445.

Boston, April 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Optimization and Digital Bio-manufacturing: Global Markets” is expected to grow from $24.3...

RetinalGenix Technologies to Participate at 2025 Roth Conference and will discuss patented remote monitoring high-resolution retinal imaging and biomarkers

RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes

MORRISVILLE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in integrated multi-omics solutions, is proud to announce the addition of two distinguished professionals, Paul McEwan and...

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay

TAIPEI, Taiwan and WATERTOWN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, today announced that...

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases